The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.
The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters. Patients will start measuring in the week prior to the first cycle of chemotherapy, target is at least 4 to 7 days before initiation of chemotherapy. Patients were the Fitbit as much as possible, during day and night. Patients continuously carry the Fitbit during the first 3 months of systemic treatment, which tracks their vital signs. At the starting day of the next cycle of chemotherapy patients will have an appointment with one of the researchers to evaluate the use of the Fitbit. Furthermore, it will be checked if a patient has returned to their baseline vital signs.
Study Type
OBSERVATIONAL
Enrollment
175
Proactive monitoring of vital signs for the duration of the first two cycles of chemotherapy by using a Fitbit
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands
RECRUITINGVariance and normalization of resting heart rate
Variance and normalization of resting heart rate in bpm over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of maximum heart rate
Variance and normalization of vital parameters maximum heart rate in bpm over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of minimum heart rate
Variance and normalization of minimum heart rate in bpm over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of heart rate variability
Variance and normalization of vital parameters heart rate variability over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of respiratory rate
Variance and normalization of respiratory rate in absolute numbers over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of blood pressure
Variance and normalization of blood pressure in mmHG over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of step count
Variance and normalization of step count in absolute numbers over time during chemotherapy
Time frame: Through study completion, an average of 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Variance and normalisation of blood oxygen saturation
Variance and normalization of blood oxygen saturation in percentage over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of sleep time
Variance and normalization of sleep time in hours over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Variance and normalisation of sleep quality
Variance and normalization of sleep quality on a scale from 1 to 10 over time during chemotherapy
Time frame: Through study completion, an average of 6 months
Contact with healthcare provider
Number of contact moments with a healthcare provider (nurse, nurse practioner, general practioner, treating physician)
Time frame: Through study completion, an average of 6 months
emergency department visits
Number of emergency department visits
Time frame: Through study completion, an average of 6 months
Toxicity
Toxicity, defined as a grade between 1 and 4, documented in electronic patient file
Time frame: Through study completion, an average of 6 months
Dose Modification of chemotherapy
Modification in dosage of chemotherapy, documented in electronic patient file
Time frame: Through study completion, an average of 6 months